To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

This bill changes the rules for when Medicare can negotiate lower prices for prescription drugs. Currently, regular drugs must be on the market for at least 7 years before Medicare can negotiate their prices, while biologic drugs must be on the market for at least 11 years. This bill would require all drugs, including regular drugs, to be on the market for at least 11 years before Medicare can negotiate their prices. These changes would apply to drugs that are already being considered for price negotiation.

Your Vote